2024-09-22 - Analysis Report
## HCA Healthcare Inc. (HCA) Stock Analysis

**Company Overview:** HCA Healthcare Inc. is a leading healthcare provider in the United States.

**1. Performance Comparison:**

* **Cumulative Return:** HCA has generated a cumulative return of 334.28%, significantly outperforming the S&P 500 (VOO) which has returned 132.46%.
* **Relative Performance:** HCA currently holds a relative outperformance level of 99.34% compared to the S&P 500. This means that HCA has been consistently outperforming the S&P 500 over the observed period, reaching almost the peak of its historical outperformance.

**2. Recent Price Movement:**

* **Closing Price:** $404.66
* **5-Day Moving Average:** $401.42
* **20-Day Moving Average:** $393.77
* **60-Day Moving Average:** $361.14

**3. Technical Indicators:**

* **RSI:** 59.84 - The stock is currently in the neutral zone, indicating neither overbought nor oversold conditions.
* **PPO:** -0.12 -  The PPO is slightly negative, suggesting a potential short-term weakness.
* **Delta_Previous_Relative_Divergence:** -0.66 - This negative value indicates a short-term downward trend in the relative performance compared to the benchmark.
* **Expected Return:** 1.34% - This indicates a potential return on investment within a 5-year timeframe. 

**4. Recent Earnings and Outlook:**

| Date         | EPS | Revenue         |
|--------------|-----|------------------|
| 2024-07-29   | 5.6 | $17.49 Billion |
| 2024-05-02   | 6.01| $17.34 Billion |
| 2023-10-26   | 3.98| $16.21 Billion |
| 2023-08-02   | 4.35| $15.86 Billion |
| 2024-07-29   | 4.35| $15.86 Billion |

HCA's recent earnings have been strong and have surpassed analyst expectations. The company continues to benefit from a favorable healthcare environment and its strong market position.

**5. Overall Analysis:**

HCA Healthcare Inc. (HCA) has consistently outperformed the S&P 500, displaying strong relative performance and generating impressive returns. While current technical indicators point to a potential short-term weakness, the company's robust earnings performance and positive outlook suggest a strong underlying growth potential. The company remains a strong investment option with a healthy return potential. 
